Pierre Fabre: Breast Neoplasms trials

The registry lists 11 Breast Neoplasms studies with Pierre Fabre as lead sponsor. 1 are open to participants now and 6 have results posted.

Phase 2 1Phase 3 4No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Treatment Patterns of Neratinib in HER2+ EBC in ChinaNot yet recruitingNCT05491057
• A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With NeratinibCompletedNCT05599334Results posted
• Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast CancerCompletedNCT03887130Phase 2Results posted
• A Study of Vinflunine Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine in Patients With Advanced Breast CancerTerminatedNCT02054338Phase 3Results posted
• Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerCompletedNCT01953003Phase 3Results posted
• Trial of Vinflunine Plus Capecitabine in Advanced Breast CancerCompletedNCT01095003Phase 3Results posted
• Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast CancerCompletedNCT01091168Phase 3Results posted
• An Observational Real-world Study to Evaluate the Impact of Dermatological Toxicities on the Quality of Life in Patients With Early Breast Cancer Treated With Adjuvant Endocrine Therapy - BCARE (Breast Cancer Adjuvant Real-world Evaluation of Dermatological Adverse Events)CompletedNCT06690489
• Real-life Pan-HER-blockade With NeratinibCompletedNCT04388384
• Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and AustriaCompletedNCT02619929
• Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)CompletedNCT00890903